Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. [electronic resource]
Producer: 20180829Description: 209-215 p. digitalISSN:- 1177-8881
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.